Most cited−20%
Metabolic Research
Semaglutide
GLP-1 receptor agonist reference standard for incretin-pathway research.
≥99.5%4.5(6)
from$68.00$85.00
NewRetatrutide
Triple GIP/GLP-1/glucagon receptor agonist reference compound.
Batch RTT-0924A · 99.12%
$195.00$240.00Save 19%
Price per vial, excluding shipping. Free shipping over $200.00.
Size
In stock — ships today if ordered before 14:00
1
Dispatched same business day before 14:00
Cold-chain packed free of charge
All products are sold strictly as laboratory research chemicals. Not for human or veterinary consumption.
Research context
Retatrutide is a single-molecule triple agonist at the GIP, GLP-1 and glucagon receptors. It is of significant interest in comparative receptor pharmacology because it allows a single tool compound to interrogate three related class-B GPCRs simultaneously.
Lyophilized powder, sterile filtered. COA published per batch.
Studied in
- Triple-agonist receptor pharmacology
- Glucagon receptor signalling studies
- Energy-expenditure model research
Related compounds